HNRNPH1 and acute lymphoblastic leukemia: Specifically, near-haploid B-ALL cells bearing such a mixed G2/M and G1/S checkpoint signature were enriched upon combination therapy, while those expressing high levels of HNRNPH1 were relatively depleting, suggesting decreased relative fitness compared to other cells upon chemotherapy.